Source: AI

CHAR Technologies as a pioneer of decentralized pyrolysis

CHAR Technologies has positioned itself in the field of decentralized resource recovery. Its business model addresses two enormous industrial problems at the same time: expensive waste disposal and the need for climate-neutral energy. The technological core is high-temperature pyrolysis, which breaks down organic materials at over 800 degrees Celsius into solid biochar and energy-rich synthesis gas. The biochar can replace fossil coal in the steel and metal industry almost one-to-one, while the gas produced is used for heat, renewable natural gas, or green hydrogen. The company has also achieved a groundbreaking success in wastewater treatment. In a project in the US, CHAR demonstrated that the plant can destroy the dangerous and extremely persistent PFAS chemicals in sewage sludge. This opens up a massive growth market for the company among municipalities that are suffering from increasingly stringent regulations and the aforementioned “forever chemicals.”

Smart licenses and strong partners conserve capital

Operationally, the company is currently taking the decisive step from developer to producer. With the current commissioning of the first phase of its flagship Canadian project in Thorold, CHAR is proving the industrial scalability of its technology. A second biochar project in Espanola, on the site of a former pulp mill, is already in the starting blocks. In order to grow rapidly internationally without tying up a huge amount of its own capital, the management is focusing on smart partnerships. For example, a license agreement with a French developer secures future market entry in Europe and promises attractive margins through ongoing royalties. Investors are also increasingly focusing on the stock, which is also listed in Germany. The BMI Group is massively expanding its financial commitment to CHAR. It is likely to hold more than 10% of the shares in the future, which demonstrates investor confidence in the technology.

Good opportunity? CHAR Technologies shares are in a wait-and-see position.

Linde supplies the infrastructure for clean gas

While CHAR offers decentralized solutions for smaller companies, the gas group Linde supplies the central building blocks for large-scale industrial decarbonization. The world’s largest industrial gas company covers the entire hydrogen value chain and builds huge electrolysers as well as distribution and cryogenic storage facilities. A prime example of this strategic orientation is the planned construction of a 100-megawatt electrolyser for the Shell chemical park in the Rhineland, which is expected to supply clean energy from 2027. Such infrastructure forms the backbone of large-scale domestic industry. Financially, the group is operating from a position of strength. With a project portfolio of USD 10 billion, 65% of which is accounted for by clean energies, and enormous pricing power thanks to long-term contracts, Linde offers investors a safe haven against short-term fluctuations.

The technological link between these two worlds is provided by materials specialist DuPont. The company manufactures the components that are essential for the efficient operation of modern energy plants. Whether it is highly efficient specialty materials for gas purification at Linde or complex water treatment systems for cooling and steam generation in pyrolysis plants such as those at CHAR, DuPont supplies the building blocks. A current example is a new reverse osmosis membrane that purifies industrial wastewater under extremely high pressure, maximizing water recovery while reducing energy consumption. In times of persistently high electricity costs, this is a decisive competitive advantage for industrial customers.

For investors, this trio represents an excellent mix. Linde and DuPont form the established and stable core investments for the portfolio. At the same time, CHAR Technologies offers speculative investors a dynamic return opportunity for the future, given the start of commercial production and the solution to highly topical waste disposal problems. Despite operational progress in recent weeks, CHAR’s share price has fallen back. Investors should keep an eye on the stock, as the business model and expansion into Europe sound promising.


Conflict of interest

Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as “Relevant Persons”) may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a “Transaction”). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

For this reason, there is a concrete conflict of interest.

The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

Risk notice

Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.

More From The Market Online

Drone revolution and defense boom: Why Volatus Aerospace is emerging as a new aerospace player

The daily news reports currently begin with war coverage. This is not a desirable situation, but it is a bitter reality. Nowadays, much reconnaissance…

Underestimated prospects in the precious metals sector: Lahontan Gold, Barrick Mining, and First Majestic Silver are the favorites

Market volatility has skyrocketed in the wake of new global armed conflicts. This trend is evident across all asset classes. Investors are currently focusing…

AI fuels demand, investors reap rewards: ExxonMobil, Standard Uranium, and Nordex in focus

Electricity demand is exploding, driven by electrification and the race for supremacy in artificial intelligence. Governments and corporations are desperately searching for solutions to…

Breaking News! Takeover speculation? BioNTech, Evotec, Vidac Pharma

First, the positive news: Vidac Pharma's drug candidate VDA-1102 was recently used in a compassionate treatment case in connection with a girl's third brain…